Indeed, our results have identified the over-activation of CaMKII in MM treated LAMP2 KO DD models, confirming the potential role of CaMKII oxidation and activation during the pathogenesis of arrhythmia in DD patients. This evidence concerns the gene CAMK2G and cardiac arrhythmia.